Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenobamate in Japanese Pediatric Patients With Partial-Onset Seizures
NCT07594158Phase 3Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cenobamate in partial epilepsy, sponsored by Ono Pharmaceutical. Started Jun 2026; status: recruiting.
02
Drugs
cenobamate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT07594158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07594158.